Your Impartial, Comprehensive Daily News Source

Abbott restarts in Sturgis

Abbott Nutrition restarted production of some types of baby formula at its plant in Sturgis, Michigan, over the weekend, a step many hope will help ease a nationwide shortage. The company said it would begin with EleCare, a product meant for infants with digestive issues.

Abbott, which also produces Similac, accounts for more than 40% of the US baby formula market. The Sturgis plant was voluntarily shut down in February after a number of infants were diagnosed with bacterial infections after consuming formula made at the facility. Two infants ultimately died from infections, though the company has said testing at the plant did not establish a direct link with the cases. Production is restarting following approval from the Food and Drug Administration per guidelines from a May agreement.  

The Sturgis shutdown exacerbated existing pandemic-related supply chain issues, with out-of-stock rates hitting 74% by the end of May. See an overview of the shortage here.